These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23489260)

  • 21. The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
    Schippinger W; Regitnig P; Bauernhofer T; Ploner F; Hofmann G; Krippl P; Wehrschütz M; Lax S; Carney W; Neumann R; Wernecke KD; Samonigg H
    Oncol Rep; 2004 Jun; 11(6):1331-6. PubMed ID: 15138574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High co-expression of Sp1 and HER-2 is correlated with poor prognosis of gastric cancer patients.
    Jiang W; Jin Z; Zhou F; Cui J; Wang L; Wang L
    Surg Oncol; 2015 Sep; 24(3):220-5. PubMed ID: 26096373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
    Press MF; Pike MC; Hung G; Zhou JY; Ma Y; George J; Dietz-Band J; James W; Slamon DJ; Batsakis JG
    Cancer Res; 1994 Nov; 54(21):5675-82. PubMed ID: 7522962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y; Zhang XR; Fu J; Tan W; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
    Zhou F; Li N; Jiang W; Hua Z; Xia L; Wei Q; Wang L
    World J Surg Oncol; 2012 Dec; 10():274. PubMed ID: 23249720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
    Lee EY; Cibull ML; Strodel WE; Haley JV
    Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
    Saffari B; Jones LA; el-Naggar A; Felix JC; George J; Press MF
    Cancer Res; 1995 Dec; 55(23):5693-8. PubMed ID: 7585656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
    Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M
    Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of HER 2/neu gene amplification with immunohistochemistry and other prognostic factors in breast carcinoma.
    Ramadan SS; Yapicier O; Kıhtır S; Erdemır A; Doğan TH; Uskent I; Onat H; Cakmakçi M
    Turk Patoloji Derg; 2011; 27(3):196-203. PubMed ID: 21935868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Her-2/neu assessment for gastric carcinoma: validation of scoring system.
    Mrklic I; Bendic A; Kunac N; Bezic J; Forempoher G; Durdov MG; Karaman I; Prusac IK; Pisac VP; Vilovic K; Tomic S
    Hepatogastroenterology; 2012; 59(113):300-3. PubMed ID: 22260838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
    Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
    Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N; Grenert JP; Sahai V; Kakar S
    Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
    Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in gastric cancer.
    Brien TP; Depowski PL; Sheehan CE; Ross JS; McKenna BJ
    Mod Pathol; 1998 Sep; 11(9):870-7. PubMed ID: 9758367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER-2/neu oncogene and estrogen receptor expression in non small cell lung cancer patients.
    Alerić I; Razumović JJ; Koprivica B
    Med Pregl; 2012; 65(5-6):210-5. PubMed ID: 22730705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.